Why "Normal" Blood Test Results Don't Always Mean You're Healthy
Your lab results came back "within range" — but you still feel exhausted, foggy, or just not yourself. Here's why standard reference ranges can miss early warning signs, and what to look for instead.
The "Normal" Trap
You get your blood work done. Your doctor glances at the results and says, "Everything looks normal." But you still feel tired. Your brain is foggy. You can't explain why your energy dips every afternoon or why your sleep feels unrestorative.
This disconnect is more common than you think, and the reason lies in how lab reference ranges are defined.
Standard reference ranges represent the middle 95% of a given population sample. They're designed to flag overt disease, not to tell you whether you're thriving. The people included in those population samples often weren't screened for early-stage dysfunction — meaning the "normal" range can be skewed by people who are already developing problems but haven't been diagnosed yet.[1]
The result: a lab report that says "normal" when your body is already sending signals that something is off.
Reference Ranges vs. Optimal Ranges: Four Biomarkers That Illustrate the Gap
Optimal ranges are narrower windows within the standard range, supported by research linking specific levels to better health outcomes and lower disease risk. Here are four common biomarkers where the gap between "normal" and "optimal" matters most.
Ferritin (Iron Stores)
Most labs report ferritin as normal starting at 12–15 ng/mL for women. But a 2024 systematic review in The Lancet Haematology found that many of the population samples used to establish these lower limits did not exclude iron-deficient individuals, dragging the cutoff artificially low.[1]
A randomized controlled trial published in CMAJ found that women with unexplained fatigue and ferritin below 50 ng/mL saw a 48% reduction in fatigue after iron supplementation, compared to 29% with placebo.[2] A clinical review in Clinical Medicine concluded that iron deficiency without anemia — affecting an estimated 2.4 billion people globally — causes fatigue, cognitive impairment, and reduced exercise performance even when hemoglobin is completely normal.[3]
Vitamin D
Many labs report vitamin D as sufficient starting at 30 ng/mL. The 2011 Endocrine Society Clinical Practice Guideline, however, recommended a preferred range of 40–60 ng/mL for maximum health benefits.[4]
A study of over 24,000 patients found that the lowest mortality was in patients with vitamin D levels between 30–50 ng/mL, with both lower and higher levels associated with increased risk — a U-shaped curve.[5] A meta-analysis of randomized controlled trials published in Annals of Oncology found that vitamin D supplementation reduced total cancer mortality by 13%.[6]
TSH (Thyroid-Stimulating Hormone)
The standard TSH reference range spans 0.4–4.0 mIU/L, but the NHANES III population study found that the median TSH among healthy U.S. adults was just 1.39 mIU/L, and over 80% of the population fell below 2.5 mIU/L.[7]
The National Academy of Clinical Biochemistry stated that more than 95% of healthy euthyroid individuals have TSH between 0.4–2.5 mIU/L, suggesting that values above 2.5 may indicate early thyroid failure.[8] A 2023 meta-analysis of 134,346 participants in The Lancet Diabetes & Endocrinology confirmed that cardiovascular risk and mortality increase outside a narrower optimal TSH window.[9]
Fasting Glucose
The ADA classifies fasting glucose below 100 mg/dL as "normal." But a landmark study in the New England Journal of Medicine found that young men with fasting glucose of 91–99 mg/dL had significantly elevated risk of developing type 2 diabetes.[10]
A study of nearly 11,000 adults found that those with fasting glucose of 95–99 mg/dL had a 53% higher risk of cardiovascular events compared to those below 80 mg/dL, even after adjusting for other risk factors.[11] Research from the Panasonic Cohort Study showed that diabetes risk increased 9% per 1 mg/dL increase within the 90–99 range.[12]
The Big Picture
| Biomarker | Typical Lab "Normal" | Research-Supported Optimal |
|---|---|---|
| Ferritin | 12–300 ng/mL | 50–100 ng/mL |
| Vitamin D | ≥30 ng/mL | 40–60 ng/mL |
| TSH | 0.4–4.0 mIU/L | 0.5–2.5 mIU/L |
| Fasting Glucose | <100 mg/dL | 72–85 mg/dL |
The Hidden Connections Your Lab Report Doesn't Show
Standard lab reports present each biomarker in isolation, but your body doesn't work that way. Biomarkers interact, and understanding these relationships can reveal root causes that individual numbers miss.
Vitamin D and Calcium
The active form of vitamin D (1,25-dihydroxyvitamin D3) is the primary driver of intestinal calcium absorption. Without adequate vitamin D, your body cannot efficiently absorb dietary calcium — regardless of how much calcium you consume. When this happens, the body compensates by pulling calcium from bone, which can contribute to bone loss over time.[13]
This means that a "normal" calcium level on your lab report might be masking a vitamin D problem: your body is maintaining serum calcium at the expense of your bones.
Iron, Ferritin, and TIBC
Serum iron alone is considered one of the least reliable parameters for assessing iron status because it fluctuates throughout the day and responds to recent dietary intake. Ferritin reflects iron stores but rises during inflammation, potentially masking a true deficiency. TIBC (Total Iron-Binding Capacity) and transferrin saturation complete the picture by measuring how much iron your blood can transport.[14]
You need the full iron panel — not just individual values — to accurately distinguish between iron deficiency, inflammation-driven changes, and iron overload. Learn more about ferritin in our biomarker guide.
TSH, FT3, and FT4
TSH is the standard first-line thyroid screening test, but it can miss functional thyroid issues. About 80% of the active thyroid hormone T3 is produced outside the thyroid gland through conversion from T4 in the liver and kidneys. The pituitary gland — which produces TSH — has a different enzyme profile than peripheral tissues, meaning it may sense adequate thyroid hormone locally while other tissues remain deficient.[15]
A normal TSH with low FT3 can indicate impaired conversion, which may explain persistent symptoms like fatigue and brain fog despite "normal" thyroid numbers.[16]
Key takeaway: Looking at biomarkers in isolation is like reading every other word in a sentence. The interactions between your markers often reveal more than any single number can.
5 Steps to Go Beyond "Normal"
- Request specific tests beyond the basic panel. A standard metabolic panel misses markers like ferritin, vitamin D, FT3/FT4, and insulin. Ask your doctor for a more comprehensive workup if you have unexplained symptoms.
- Track trends over time, not just single snapshots. A single blood test is a photograph; multiple tests over months reveal a movie. A ferritin of 35 ng/mL that was 70 six months ago tells a very different story than a stable 35.
- Compare your results against optimal ranges. Knowing your value is "within range" isn't enough. Check where you fall within that range and whether research supports a narrower optimal window for that biomarker.
- Look at biomarker relationships, not just isolated numbers. Pair your vitamin D with your calcium. Look at your full iron panel, not just serum iron. Evaluate TSH alongside FT3 and FT4 for the complete thyroid picture.
- Bring better data to your doctor. Your healthcare provider has limited time. Arriving with organized, trended data and flagged concerns makes for a more productive conversation and helps you advocate for your health.
See the Full Picture With Health3
Health3 was built to solve exactly this problem. Scan your lab results, see what's "normal but not optimal," explore how your biomarkers interact, and track your trends over time.
References
- Truong J, et al. "The origin of ferritin reference intervals: a systematic review." The Lancet Haematology. 2024;11(7):e530-e539. PubMed
- Vaucher P, et al. "Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial." CMAJ. 2012;184(11):1247-1254. PubMed
- Al-Naseem A, et al. "Iron deficiency without anaemia: a diagnosis that matters." Clinical Medicine. 2021;21(2):107-113. PubMed
- Holick MF, et al. "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2011;96(7):1911-1930. PubMed
- Dudenkov DV, et al. "Serum 25-Hydroxyvitamin D Values and Risk of All-Cause and Cause-Specific Mortality." Mayo Clinic Proceedings. 2015;90(7):911-921. PubMed
- Keum N, et al. "Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials." Annals of Oncology. 2019;30(5):733-743. PubMed
- Hollowell JG, et al. "Serum TSH, T(4), and Thyroid Antibodies in the United States Population (1988 to 1994): NHANES III." J Clin Endocrinol Metab. 2002;87(2):489-499. PubMed
- Wartofsky L, Dickey RA. "The Evidence for a Narrower Thyrotropin Reference Range Is Compelling." J Clin Endocrinol Metab. 2005;90(9):5483-5488. Oxford Academic
- Xu Y, et al. "The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis." Lancet Diabetes Endocrinol. 2023;11(10):743-754. PubMed
- Tirosh A, et al. "Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men." N Engl J Med. 2005;353(14):1454-1462. PubMed
- Kivity S, et al. "Fasting glucose levels within the high normal range predict cardiovascular outcome." Am Heart J. 2012;164(1):111-116. PubMed
- Munekawa C, et al. "Fasting plasma glucose level in the range of 90-99 mg/dL and the risk of the onset of type 2 diabetes." J Diabetes Investig. 2022;13(3):453-459. PubMed
- Christakos S, et al. "Vitamin D and intestinal calcium absorption." Mol Cell Endocrinol. 2011;347(1-2):25-29. PubMed
- StatPearls. "Iron-Binding Capacity." NCBI Bookshelf. NCBI Bookshelf
- Koulouri O, et al. "How to interpret thyroid function tests." Clin Med (Lond). 2013;13(3):282-286. PMC
- Bianco AC, et al. "The relevance of T3 in the management of hypothyroidism." Lancet Diabetes Endocrinol. 2023;11(4):291-300. PMC
Medical Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. The optimal ranges discussed are based on published research and may not apply to every individual. Always consult a qualified healthcare professional before making changes to your health regimen. Read our full Content Standards & Medical Disclaimer.